105 related articles for article (PubMed ID: 2820631)
1. Immune response to oral polio vaccine in patients with IgA glomerulonephritis.
Leinikki PO; Mustonen J; Pasternack A
Clin Exp Immunol; 1987 Apr; 68(1):33-8. PubMed ID: 2820631
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune response in patients with IgA and IgM glomerulonephritis.
Pasternack A; Mustonen J; Leinikki P
Clin Exp Immunol; 1986 Jan; 63(1):228-33. PubMed ID: 3955883
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune response to oral polio immunization in patients with IgA nephropathy.
Waldo FB; Cochran AM
J Clin Lab Immunol; 1989 Mar; 28(3):109-14. PubMed ID: 2738908
[TBL] [Abstract][Full Text] [Related]
4. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional sero epidemiological prevalence of polio virus antibodies post-immunization with three doses of TOPV.
Tswana SA; Berejena C; Moyo SR; Mudyarabikwa O
Cent Afr J Med; 1994 Nov; 40(11):303-5. PubMed ID: 7859270
[TBL] [Abstract][Full Text] [Related]
6. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
[TBL] [Abstract][Full Text] [Related]
7. Preexisting poliovirus-specific IgA in the circulation correlates with protection against virus excretion in the elderly.
Buisman AM; Abbink F; Schepp RM; Sonsma JA; Herremans T; Kimman TG
J Infect Dis; 2008 Mar; 197(5):698-706. PubMed ID: 18279050
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity in monkeys of two polio type 3 seed viruses (SO + 2 and SOR + 1) presently used for production of oral polio vaccine.
Sokhey J; Sharma B; Singh H
J Commun Dis; 1989 Dec; 21(4):301-8. PubMed ID: 2561635
[TBL] [Abstract][Full Text] [Related]
9. Mucosal and systemic immunity against poliovirus in mice transgenic for the poliovirus receptor: the poliovirus receptor is necessary for a virus-specific mucosal IgA response.
Buisman AM; Sonsma JA; Kimman TG; Koopmans MP
J Infect Dis; 2000 Mar; 181(3):815-23. PubMed ID: 10720499
[TBL] [Abstract][Full Text] [Related]
10. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
[TBL] [Abstract][Full Text] [Related]
11. In vivo alteration of antibody production in patients with IgA nephropathy.
Endoh M; Suga T; Miura M; Tomino Y; Nomoto Y; Sakai H
Clin Exp Immunol; 1984 Sep; 57(3):564-70. PubMed ID: 6380836
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus.
Hyöty H; Huupponen T; Leinikki P
Clin Exp Immunol; 1985 Apr; 60(1):139-44. PubMed ID: 4006299
[TBL] [Abstract][Full Text] [Related]
14. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
[TBL] [Abstract][Full Text] [Related]
15. The immunoglobulin class responses to oral poliovaccine in coeliac disease.
Mawhinney H; Love AH
Clin Exp Immunol; 1975 Sep; 21(3):399-406. PubMed ID: 1106924
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of anti-polio and anti-HSV IgA pre-plasma cell response in blood following parenteral immunization with tetanus-diphtheria vaccine.
Fernandes JR; Wasserman S; Snider DP
Vaccine; 2010 Feb; 28(6):1493-8. PubMed ID: 20003921
[TBL] [Abstract][Full Text] [Related]
17. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
Samoilovich E; Roivainen M; Titov LP; Hovi T
J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
[TBL] [Abstract][Full Text] [Related]
18. [Surveillance of levels of neutralizing antibodies against poliovirus among children aged 0-3 in rural areas of Anhui Province].
Shen Y; Zhao Y; Liu D
Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):335-8. PubMed ID: 8697935
[TBL] [Abstract][Full Text] [Related]
19. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
[TBL] [Abstract][Full Text] [Related]
20. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
